Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Saved in:

Bibliographic Details
Published in:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Main Author:	Niazi, Sarfaraz K
Published:	MDPI AG
Subjects:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Online Access:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!